Kommersant publication with reference to the head of the Center for Mathematical Modeling in development
The problem is that without officialdocumented studies, drugs cannot be registered. Peskov clarified that, according to statistics, 5-10% of projects end with the launch of the drug on the market, which makes it possible to recoup all investments.
Among the 300 drugs that may disappear from the Russian market, there are those needed for "breakthrough therapy", for the treatment of diseases that are considered incurable.
At the same time, experts believe that the Russianthe pharmaceutical industry will not be able to provide the domestic market with analogues of outdated drugs. The reason is the difficulties with the supply of equipment, reagents and the departure of specialists.